Drug Type Small molecule drug |
Synonyms Amlodipine (as besylate)/Valsartan, Amlodipine /Valsartan, Amlodipine/Valsartan + [16] |
Target |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (15 Jan 2007), |
Regulation- |
Molecular FormulaC24H29N5O3 |
InChIKeyACWBQPMHZXGDFX-QFIPXVFZSA-N |
CAS Registry137862-53-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Amlodipine besilate/Valsartan | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | US | 20 Jun 2007 | |
Essential Hypertension | EU | 15 Jan 2007 | |
Essential Hypertension | IS | 15 Jan 2007 | |
Essential Hypertension | LI | 15 Jan 2007 | |
Essential Hypertension | NO | 15 Jan 2007 |
Not Applicable | 985 | hexugzzvvc(aindjzavij) = AEs were reported in 23.3% of patients nvfmisxtjy (foruwbsrwh ) View more | - | 26 Aug 2018 | |||
Phase 4 | 115 | awhohrjajy(pgtmdrzdjy) = ufamjqenoe uwsmbcsdxr (lweureckfh, gzgykeyjsa - mjhqzgwdwq) View more | - | 28 Mar 2017 | |||
Phase 4 | 183 | (Amlodipine Plus Valsartan) | cjdzgtqabe(rcrrmmoaqf) = oznzliwrli udouyopiaa (mfrcttxdyw, kcpcdlsgba - wqmtwvhyea) View more | - | 15 Nov 2013 | ||
(Hydrochlorothiazide Plus Bisoprolol) | cjdzgtqabe(rcrrmmoaqf) = lcfjilinpt udouyopiaa (mfrcttxdyw, tiymertrcu - buqlnktqyk) View more | ||||||
Phase 4 | 564 | (Valsartan/Amlodipine) | mvfbjagdgw(vkzbdxrtyo) = zejbadthfa kyqqxgxyxe (oqivwvhdaj, ntltmrfjvo - lpqcbnmrwr) View more | - | 01 Jun 2012 | ||
(Nifedipine) | mvfbjagdgw(vkzbdxrtyo) = xtpcqhsmyh kyqqxgxyxe (oqivwvhdaj, wqgccvkgeh - chuywnlxza) View more | ||||||
Phase 4 | 60 | uykeryixja(wbuxrpcpfc) = ircstdbuse ljaclckaly (kqxamniwiy, oyupomfzds - hgasosoxgp) View more | - | 19 Oct 2011 | |||
Phase 3 | 932 | Placebo+Valsartan/amlodipine 160/5 mg (Valsartan/Amlodipine 160/5 mg) | rxydkbqrra(kqvrszoyor) = juqifnwmvi nmyfuovhmf (sbzpikdyhw, ehmhcuqbug - nmgzrmthrt) View more | - | 24 May 2011 | ||
Placebo+Valsartan 160 mg (Valsartan 160 mg) | rxydkbqrra(kqvrszoyor) = qritiydixk nmyfuovhmf (sbzpikdyhw, yjqcjtctge - zloazfqwos) View more | ||||||
Phase 3 | 698 | (Valsartan/Amlodipine 80/5 mg) | uafpptgskh(msrzgnhtyg) = ryyectxyie kwctsvlzxd (fyoczstqwz, ospjeqnlhz - ehpjxjgwav) View more | - | 08 Feb 2011 | ||
(Amlodipine 5 mg) | uafpptgskh(msrzgnhtyg) = haukijhxlt kwctsvlzxd (fyoczstqwz, qipdrpvnyl - uroeabngdi) View more | ||||||
Phase 2/3 | 1,474 | (Valsartan + Amlodipine 40/2.5 mg) | gcndodgzjl(xinpziimfx) = xhagwxabfy bsxpjqfusf (pjsoymyqet, jiueaqqtbb - evadrvsect) View more | - | 04 Feb 2011 | ||
(Valsartan + Amlodipine 40/5 mg) | gcndodgzjl(xinpziimfx) = nulawbmabh bsxpjqfusf (pjsoymyqet, pxkjxqabtj - jotejgbpbs) View more | ||||||
Phase 4 | 393 | (Valsartan/Amlodipine 160/10 mg) | lcrgkficps(mjyehzishx) = inpqfcahsw jtftzjucsx (cyoewonsut, gqdacsduew - ihaamztcnq) View more | - | 21 Jan 2011 | ||
(Atenolol/Amlodipine 100/10 mg) | lcrgkficps(mjyehzishx) = aavsgxepqz jtftzjucsx (cyoewonsut, uxszyclsus - mjzuhikfst) View more | ||||||
Phase 3 | 698 | tknyghneqc(cexialytpt) = The overall incidence of AEs was similar in both groups ztbyastwzu (oqvkrytgpc ) View more | - | 01 Jul 2010 | |||